By Scientia Professor Louisa Jane Degenhardt

Journal articles

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394

Tran AD; Grebely J; Chambers M; Degenhardt L; Farrell M; Bajis S; Larance B, 2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, 43, pp. 997 - 1012, http://dx.doi.org/10.1111/dar.13823

Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB, 2024, 'Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study', Drug and Alcohol Review, 43, pp. 1019 - 1028, http://dx.doi.org/10.1111/dar.13828

Price O; Swanton R; Grebely J; Hajarizadeh B; Webb P; Peacock A; Dore GJ; Cowie BC; Vickerman P; Degenhardt L, 2024, 'Vaccination coverage among people who inject drugs: A systematic review', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104382

Price O; Dietze P; Maher L; Dore GJ; Sutherland R; Salom C; Bruno R; Crawford S; Degenhardt L; Larney S; Peacock A, 2024, 'High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs', Vaccine, 42, pp. 2877 - 2885, http://dx.doi.org/10.1016/j.vaccine.2024.03.051

Hopkins RE; Bharat C; Buizen L; Close J; Ivers R; Draper B; Pearson SA; Degenhardt L; Gisev N, 2024, 'Age-Related Risk of Serious Fall Events and Opioid Analgesic Use', JAMA Internal Medicine, 184, pp. 394 - 401, http://dx.doi.org/10.1001/jamainternmed.2023.8154

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Nielsen S; Degenhardt L; Farrell M, 2024, 'Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence', International Journal of Drug Policy, 126, pp. 104359, http://dx.doi.org/10.1016/j.drugpo.2024.104359

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L, 2024, 'Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104287

Bharat C; Chidwick K; Gisev N; Farrell M; Ali R; Degenhardt L, 2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104255

Bharat C; Degenhardt L; Pearson SA, 2024, '"A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data" (vol 32, pg 352, 2023)', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 33, http://dx.doi.org/10.1002/pds.5714

Stein DJ; Kazdin AE; Munthali RJ; Hwang I; Harris MG; Alonso J; Andrade LH; Bruffaerts R; Cardoso G; Chardoul S; de Girolamo G; Florescu S; Gureje O; Haro JM; Karam AN; Karam EG; Kovess-Masfety V; Lee S; Medina-Mora ME; Navarro-Mateu F; Posada-Villa J; Stagnaro JC; ten Have M; Sampson NA; Kessler RC; Vigo DV; Aguilar-Gaxiola S; Al-Hamzawi A; Altwaijri YA; Atwoli L; Benjet C; Borges G; Bromet EJ; Bunting B; Caldas-de-Almeida JM; Chatterji S; Cia AH; Degenhardt L; Demyttenaere K; Hinkov H; Hu CY; de Jonge P; Karam G; Kawakami N; Kiejna A; Lepine JP; McGrath JJ; Moskalewicz J; Piazza M; Scott KM; Slade T; Torres Y; Viana MC; Whiteford H; Wojtyniak B, 2023, 'Determinants of effective treatment coverage for posttraumatic stress disorder: findings from the World Mental Health Surveys', BMC Psychiatry, 23, http://dx.doi.org/10.1186/s12888-023-04605-2

Li B; Allebeck P; Burstöm B; Danielsson AK; Degenhardt L; Eikemo TA; Ferrari A; Knudsen AK; Lundin A; Manhica H; Newton J; Whiteford H; Flodin P; Sjöqvist H; Agardh EE, 2023, 'Educational level and the risk of mental disorders, substance use disorders and self-harm in different age-groups: A cohort study covering 1,6 million subjects in the Stockholm region', International Journal of Methods in Psychiatric Research, 32, http://dx.doi.org/10.1002/mpr.1964

Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Bonn M; Wheeler A; Grebely J; Farrell M; Hickman M; Hayward A; Degenhardt L, 2023, 'Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia', International Journal of Drug Policy, 122, http://dx.doi.org/10.1016/j.drugpo.2023.104218

Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J, 2023, 'Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e1885 - e1898, http://dx.doi.org/10.1016/S2214-109X(23)00461-8

Abdel Shaheed C; Ivers R; Vizza L; McLachlan A; Kelly PJ; Blyth F; Stanaway F; Clare PJ; Thompson R; Lung T; Degenhardt L; Reid S; Martin B; Wright M; Osman R; French S; McCaffery K; Campbell G; Jenkins H; Mathieson S; Boogs M; McMaugh J; Bennett C; Maher C, 2023, 'Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): A cluster randomised controlled trial protocol', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-075286

Hobday S; Valerio H; Combo T; Monaghan R; Scott C; Silk D; Murray C; Read P; Henderson C; Degenhardt L; Treloar C; Dore GJ; Grebely J; Martinello M, 2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723

Downing BC; Hickman M; Jones NR; Larney S; Sweeting MJ; Xu Y; Farrell M; Degenhardt L; Jones HE, 2023, 'Prevalence of opioid dependence in New South Wales, Australia, 2014–16: Indirect estimation from multiple data sources using a Bayesian approach', Addiction, 118, pp. 1994 - 2006, http://dx.doi.org/10.1111/add.16268

McGrath JJ; Al-Hamzawi A; Alonso J; Altwaijri Y; Andrade LH; Bromet EJ; Bruffaerts R; Caldas de Almeida JM; Chardoul S; Chiu WT; Degenhardt L; Demler OV; Ferry F; Gureje O; Haro JM; Karam EG; Karam G; Khaled SM; Kovess-Masfety V; Magno M; Medina-Mora ME; Moskalewicz J; Navarro-Mateu F; Nishi D; Plana-Ripoll O; Posada-Villa J; Rapsey C; Sampson NA; Stagnaro JC; Stein DJ; ten Have M; Torres Y; Vladescu C; Woodruff PW; Zarkov Z; Kessler RC; Aguilar-Gaxiola S; Altwaijri YA; Atwoli L; Benjet C; Bunting B; Cardoso G; Cía AH; De Girolamo G; Harris MG; Hinkov H; Hu CY; De Jonge P; Karam AN; Kazdin AE; Kawakami N; Kessler RC; Kiejna A; Piazza M; Scott KM; Viana MC; Vigo DV; Wojtyniak B; Xavier M; Zaslavsky AM, 2023, 'Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries', Lancet Psychiatry, 10, pp. 668 - 681, http://dx.doi.org/10.1016/S2215-0366(23)00193-1

Bharat C; Webb P; Wilkinson Z; McKetin R; Grebely J; Farrell M; Holland A; Hickman M; Tran LT; Clark B; Peacock A; Darke S; Li JH; Degenhardt L, 2023, 'Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis', Addiction, 118, pp. 1624 - 1648, http://dx.doi.org/10.1111/add.16200

Leung J; Chiu V; Man N; Yuen WS; Dobbins T; Dunlop A; Gisev N; Hall W; Larney S; Pearson SA; Degenhardt L; Peacock A; Peacock A, 2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218

Krupchanka D; Formanek T; Shield K; Rehm J; Heymans MW; Fleischmann A; Degenhardt L; Gawad T; Poznyak V, 2023, 'International monitoring of capacity of treatment systems for alcohol and drug use disorders: Methodology of the Service Capacity Index for Substance Use Disorders', International Journal of Methods in Psychiatric Research, 32, http://dx.doi.org/10.1002/mpr.1950

Havard A; Jones N; Bharat C; Gisev N; Pearson SA; Shakeshaft A; Farrell M; Degenhardt L, 2023, 'Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality', Drug and Alcohol Review, 42, pp. 1461 - 1471, http://dx.doi.org/10.1111/dar.13669

Schaffer AL; Gisev N; Blyth FM; Buckley NA; Currow D; Dobbins TA; Wilson A; Degenhardt L; Pearson SA, 2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675

Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2023, 'Perspectives and sentiments on contingency management from people who use methamphetamine', Drug and Alcohol Review, 42, pp. 1427 - 1437, http://dx.doi.org/10.1111/dar.13691

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159

Larney S; Jones NR; Hickman M; Nielsen S; Ali R; Degenhardt L, 2023, 'Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002–17', Addiction, 118, pp. 1527 - 1539, http://dx.doi.org/10.1111/add.16178

Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M, 2023, 'Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies', Lancet Psychiatry, 10, pp. 386 - 402, http://dx.doi.org/10.1016/S2215-0366(23)00095-0

Wong RXY; Farrell M; Degenhardt L; Memedovic S; Harvey SB; Petrie K, 2023, 'Substance use among vocational trainees in Australia: differences between medical specialties', Internal Medicine Journal, 53, pp. 939 - 945, http://dx.doi.org/10.1111/imj.15729

Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L, 2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310

Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A, 2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002

Johnson EC; Colbert SMC; Jeffries PW; Tillman R; Bigdeli TB; Karcher NR; Chan G; Kuperman S; Meyers JL; Nurnberger JI; Plawecki MH; Degenhardt L; Martin NG; Kamarajan C; Schuckit MA; Murray RM; Dick DM; Edenberg HJ; D’Souza DC; Forti MD; Porjesz B; Nelson EC; Agrawal A, 2023, 'Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users', Schizophrenia Bulletin, 49, pp. 778 - 787, http://dx.doi.org/10.1093/schbul/sbac196

Bharat C; Glantz MD; Aguilar-Gaxiola S; Alonso J; Bruffaerts R; Bunting B; Caldas-de-Almeida JM; Cardoso G; Chardoul S; de Jonge P; Gureje O; Haro JM; Harris MG; Karam EG; Kawakami N; Kiejna A; Kovess-Masfety V; Lee S; McGrath JJ; Moskalewicz J; Navarro-Mateu F; Rapsey C; Sampson NA; Scott KM; Tachimori H; ten Have M; Vilagut G; Wojtyniak B; Xavier M; Kessler RC; Degenhardt L, 2023, 'Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use', Addiction, 118, pp. 954 - 966, http://dx.doi.org/10.1111/add.16122

Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J, 2023, 'Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e659 - e672, http://dx.doi.org/10.1016/S2214-109X(23)00057-8

Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L, 2023, 'Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e673 - e683, http://dx.doi.org/10.1016/S2214-109X(23)00058-X

Colledge-Frisby S; Jones N; Degenhardt L; Hickman M; Padmanathan P; Santo T; Farrell M; Gisev N, 2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998

Bharat C; Degenhardt L; Pearson SA; Buizen L; Wilson A; Dobbins T; Gisev N, 2023, 'A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data', Pharmacoepidemiology and Drug Safety, 32, pp. 352 - 365, http://dx.doi.org/10.1002/pds.5567

Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A, 2023, 'Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis', Drug and Alcohol Review, 42, pp. 569 - 581, http://dx.doi.org/10.1111/dar.13595

Price O; Man N; Sutherland R; Bruno R; Dietze P; Salom C; Agramunt S; Grigg J; Degenhardt L; Peacock A, 2023, 'Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions', International Journal of Drug Policy, 113, http://dx.doi.org/10.1016/j.drugpo.2023.103976

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959

Santo T; Gisev N; Campbell G; Nelson E; Degenhardt L, 2023, 'The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence', Drug and Alcohol Dependence, 243, http://dx.doi.org/10.1016/j.drugalcdep.2022.109734

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J, 2023, 'Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103917

Conigrave JH; Wilson S; Conigrave KM; Chikritzhs T; Hayman N; Dawson A; Ali R; Perry J; Fitts MS; Degenhardt L; Doyle M; Egert S; Slade T; Ezard N; Dzidowska M; Lee KSK, 2022, '‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians', Addiction Science and Clinical Practice, 17, http://dx.doi.org/10.1186/s13722-022-00298-2

Hopkins RE; Degenhardt L; Campbell G; Farnbach S; Gisev N, 2022, '“Frustrated with the whole system”: a qualitative framework analysis of the issues faced by people accessing health services for chronic pain', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-08946-8

Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876

Gaddis N; Mathur R; Marks J; Zhou L; Quach B; Waldrop A; Levran O; Agrawal A; Randesi M; Adelson M; Jeffries PW; Martin NG; Degenhardt L; Montgomery GW; Wetherill L; Lai D; Bucholz K; Foroud T; Porjesz B; Runarsdottir V; Tyrfingsson T; Einarsson G; Gudbjartsson DF; Webb BT; Crist RC; Kranzler HR; Sherva R; Zhou H; Hulse G; Wildenauer D; Kelty E; Attia J; Holliday EG; McEvoy M; Scott RJ; Schwab SG; Maher BS; Gruza R; Kreek MJ; Nelson EC; Thorgeirsson T; Stefansson K; Berrettini WH; Gelernter J; Edenberg HJ; Bierut L; Hancock DB; Johnson EO, 2022, 'Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-21003-y

Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529

Gmelin JOH; De Vries YA; Baams L; Aguilar-Gaxiola S; Alonso J; Borges G; Bunting B; Cardoso G; Florescu S; Gureje O; Karam EG; Kawakami N; Lee S; Mneimneh Z; Navarro-Mateu F; Posada-Villa J; Rapsey C; Slade T; Stagnaro JC; Torres Y; Kessler RC; de Jonge P; Al-Hamzawi A; Alonso J; Andrade LH; Atwoli L; Benjet C; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; Chatterji S; Cia AH; Degenhardt L; Demyttenaere K; Florescu S; de Girolamo G; Haro JM; Harris M; Hinkov H; Hu CY; de Jonge P; Karam AN; Kawakami N; Kiejna A; Kovess-Masfety V; Lee S; Lepine JP; McGrath J; Medina-Mora ME; Moskalewicz J; Piazza M; Posada-Villa J; Scott KM; Stein DJ; Have MT; Viana MC; Vigo DV; Whiteford H; Wojtyniak B, 2022, 'Increased risks for mental disorders among LGB individuals: cross-national evidence from the World Mental Health Surveys', Social Psychiatry and Psychiatric Epidemiology, 57, pp. 2319 - 2332, http://dx.doi.org/10.1007/s00127-022-02320-z

Back to profile page